EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Existence of Quantum Pharmacology in Sartans: Evidence in Isolated Rabbit Iliac Arteries

Laura Kate Gadanec iD, Jordan Swiderski iD, Vasso Apostolopoulos iD, Kostantinos Kelaidonis, Veroniki P Vidali iD, Aleksander Canko, Graham J Moore, John M Matsoukas iD, Anthony Zulli

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242417559 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Laura Kate Gadanec und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia. Hauptthemen laut MEDLINE: Angiotensin II Type 1 Receptor Blockers, Hypertension. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Quantum pharmacology introduces theoretical models to describe the possibility of ultra-high dilutions to produce biological effects, which may help to explain the placebo effect observed in hypertensive clinical trials. To determine this within physiology and to evaluate novel ARBs, we tested the ability of known angiotensin II receptor blockers (ARBs) (candesartan and telmisartan) used to treat hypertension and other cardiovascular diseases, as well as novel ARBs (benzimidazole-N-biphenyl tetrazole (ACC519T), benzimidazole-bis-N,N′-biphenyl tetrazole (ACC519T(2)) and 4-butyl-N,N0-bis[[20-2Htetrazol-5-yl)biphenyl-4-yl]methyl)imidazolium bromide (BV6(K+)2), and nirmatrelvir (the active ingredient in Paxlovid) to modulate vascular contraction in iliac rings from healthy male New Zealand White rabbits in responses to various vasopressors (angiotensin A, angiotensin II and phenylephrine). Additionally, the hemodynamic effect of ACC519T and telmisartan on mean arterial pressure in conscious rabbits was determined, while the ex vivo ability of BV6(K+)2 to activate angiotensin-converting enzyme-2 (ACE2) was also investigated. We show that commercially available and novel ARBs can modulate contraction responses at ultra-high dilutions to different vasopressors. ACC519T produced a dose-dependent reduction in rabbit mean arterial pressure while BV6(K+)2 significantly increased ACE2 metabolism. The ability of ARBs to inhibit contraction responses even at ultra-low concentrations provides evidence of the existence of quantum pharmacology. Furthermore, the ability of ACC519T and BV6(K+)2 to modulate blood pressure and ACE2 activity, respectively, indicates their therapeutic potential against hypertension.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiotensin II Type 1 Receptor BlockersHypertensionRabbitsMaleAnimalsTelmisartanAngiotensin-Converting Enzyme 2Angiotensin Receptor AntagonistsIliac ArteryAngiotensin-Converting Enzyme InhibitorsBenzimidazolesTetrazolesBlood PressureBiphenyl Compounds

Stichwörter der Autor:innen

angiotensin IIangiotensin II receptor blockersbisartansinverse agonismsartans

Substanzen

Angiotensin II Type 1 Receptor BlockersTelmisartanAngiotensin-Converting Enzyme 2Angiotensin Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsBenzimidazolesTetrazolesbiphenylBiphenyl Compounds

Autor:innen und Institutionen

  • Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.
  • Immunology Program, Australian Institute for Musculoskeletal Science (AIMSS), Melbourne, VIC 3021, Australia.
  • NewDrug PC, Patras Science Park, 26 504 Patras, Greece.
  • Institute of Nanoscience and Nanotechnology, National Centre for Scientific Research "Demokritos", Ag. Paraskevi, 153 41 Athens, Greece.
  • Pepmetics Inc., 772 Murphy Place, Victoria, BC V6Y 3H4, Canada.
  • Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.

ORCID-Profile: Laura Kate Gadanec, Jordan Swiderski, Vasso Apostolopoulos, Veroniki P Vidali, John M Matsoukas

Zitieren

APA

Gadanec, L. K., Swiderski, J., Apostolopoulos, V., Kelaidonis, K., Vidali, V. P., Canko, A., Moore, G. J., Matsoukas, J. M., & Zulli, A. (2023). Existence of Quantum Pharmacology in Sartans: Evidence in Isolated Rabbit Iliac Arteries. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242417559

Vancouver

Gadanec LK, Swiderski J, Apostolopoulos V, Kelaidonis K, Vidali VP, Canko A, et al. Existence of Quantum Pharmacology in Sartans: Evidence in Isolated Rabbit Iliac Arteries. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242417559

BibTeX
@article{Gadanec2023,
  author = {Gadanec, Laura Kate and Swiderski, Jordan and Apostolopoulos, Vasso and Kelaidonis, Kostantinos and Vidali, Veroniki P and Canko, Aleksander and Moore, Graham J and Matsoukas, John M and Zulli, Anthony},
  title = {Existence of Quantum Pharmacology in Sartans: Evidence in Isolated Rabbit Iliac Arteries},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242417559}
}
Kostenlos starten →